Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Systems Collaborates with High Q Foundation on Huntington s Biomarkers

NEW YORK, April 19 (GenomeWeb News) - Proteome Systems of Sydney, Australia and the New York-based High Q Foundation announced today that they will collaborate on biomarker discovery and molecular characterization for Huntington's Disease.

 

Proteome Systems will look for changes in protein expression and modifications resulting from the malfunctioning of the Huntingtin protein. The company will then develop tests to monitor disease progression and measure outcomes of clinical trials, using its DiagnostlQ platform.

 

The company will also characterize the proteins involved in the disease to look for differences between wild-type and mutant Huntingtin proteins.

 

 

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.